tirzepatide trial obesity without diabetes New drug delivers significant and long-lasting weight loss A real-world study of tirzepatide
Description
References 1 WHO
This is based on currently available evidence and individual circumstances may differ
The day of weekly administration can be changed, if necessary, as long as the time between the 2 doses is at least 3 days (72 hours)
doi: 10.3389/fphys.2013.00090
